Backer Marianne De - Net Worth and Insider Trading
Backer Marianne De Net Worth
The estimated net worth of Backer Marianne De is at least $6 Million dollars as of 2024-08-25. Backer Marianne De is the CEO of Vir Biotechnology Inc and owns about 678,457 shares of Vir Biotechnology Inc (VIR) stock worth over $6 Million. Backer Marianne De is the Director of Arrowhead Pharmaceuticals Inc and owns about 17,000 shares of Arrowhead Pharmaceuticals Inc (ARWR) stock worth over $421,260. Backer Marianne De is also the Director of Kronos Bio Inc and owns about 2,750 shares of Kronos Bio Inc (KRON) stock worth over $2,695. Details can be seen in Backer Marianne De's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Backer Marianne De has not made any transactions after 2024-04-03 and currently still holds the listed stock(s).
Transaction Summary of Backer Marianne De
Backer Marianne De Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Backer Marianne De owns 3 companies in total, including Arrowhead Pharmaceuticals Inc (ARWR) , Kronos Bio Inc (KRON) , and Vir Biotechnology Inc (VIR) .
Click here to see the complete history of Backer Marianne De’s form 4 insider trades.
Insider Ownership Summary of Backer Marianne De
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
ARWR | Arrowhead Pharmaceuticals Inc | 2022-01-03 | director |
KRON | Kronos Bio Inc | 2021-12-01 | director |
VIR | Vir Biotechnology Inc | 2024-04-03 | Chief Executive Officer |
Backer Marianne De Latest Holdings Summary
Backer Marianne De currently owns a total of 3 stocks. Among these stocks, Backer Marianne De owns 678,457 shares of Vir Biotechnology Inc (VIR) as of April 3, 2024, with a value of $6 Million and a weighting of 93.35%. Backer Marianne De owns 17,000 shares of Arrowhead Pharmaceuticals Inc (ARWR) as of January 3, 2022, with a value of $421,260 and a weighting of 6.61%. Backer Marianne De also owns 2,750 shares of Kronos Bio Inc (KRON) as of December 1, 2021, with a value of $2,695 and a weighting of 0.04%.
Latest Holdings of Backer Marianne De
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
VIR | Vir Biotechnology Inc | 2024-04-03 | 678,457 | 8.77 | 5,950,068 |
ARWR | Arrowhead Pharmaceuticals Inc | 2022-01-03 | 17,000 | 24.78 | 421,260 |
KRON | Kronos Bio Inc | 2021-12-01 | 2,750 | 0.98 | 2,695 |
Holding Weightings of Backer Marianne De
Backer Marianne De Form 4 Trading Tracker
According to the SEC Form 4 filings, Backer Marianne De has made a total of 1 transactions in Vir Biotechnology Inc (VIR) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Vir Biotechnology Inc is the sale of 72,995 shares on April 3, 2024, which brought Backer Marianne De around $690,533.
According to the SEC Form 4 filings, Backer Marianne De has made a total of 4 transactions in Arrowhead Pharmaceuticals Inc (ARWR) over the past 5 years, including 2 buys and 2 sells. The most-recent trade in Arrowhead Pharmaceuticals Inc is the sale of 4,500 shares on January 3, 2022, which brought Backer Marianne De around $291,195.
According to the SEC Form 4 filings, Backer Marianne De has made a total of 2 transactions in Kronos Bio Inc (KRON) over the past 5 years, including 2 buys and 0 sells. The most-recent trade in Kronos Bio Inc is the acquisition of 1,150 shares on December 1, 2021, which cost Backer Marianne De around $13,306.
Insider Trading History of Backer Marianne De
- 1
Backer Marianne De Trading Performance
GuruFocus tracks the stock performance after each of Backer Marianne De's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Backer Marianne De is 3.22%. GuruFocus also compares Backer Marianne De's trading performance to market benchmark return within the same time period. The performance of stocks bought by Backer Marianne De within 3 months outperforms 1 times out of 4 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Backer Marianne De's insider trading performs compared to the benchmark.
Performance of Backer Marianne De
Backer Marianne De Ownership Network
Ownership Network List of Backer Marianne De
Ownership Network Relation of Backer Marianne De
![Insider Network Chart](https://static.gurufocus.com/insider-network.png)
Backer Marianne De Owned Company Details
What does Arrowhead Pharmaceuticals Inc do?
Who are the key executives at Arrowhead Pharmaceuticals Inc?
Backer Marianne De is the director of Arrowhead Pharmaceuticals Inc. Other key executives at Arrowhead Pharmaceuticals Inc include Chief Commercial Officer Tracie Oliver , other: Senior Vice President James C Hamilton , and CFO Kenneth Allen Myszkowski .
Arrowhead Pharmaceuticals Inc (ARWR) Insider Trades Summary
Over the past 18 months, Backer Marianne De made no insider transaction in Arrowhead Pharmaceuticals Inc (ARWR). Other recent insider transactions involving Arrowhead Pharmaceuticals Inc (ARWR) include a net sale of 266,472 shares made by Christopher Richard Anzalone , a net sale of 55,383 shares made by James C Hamilton , and a net sale of 71,104 shares made by Kenneth Allen Myszkowski .
In summary, during the past 3 months, insiders sold 9,394 shares of Arrowhead Pharmaceuticals Inc (ARWR) in total and bought 0 shares, with a net sale of 9,394 shares. During the past 18 months, 509,331 shares of Arrowhead Pharmaceuticals Inc (ARWR) were sold and 3,000 shares were bought by its insiders, resulting in a net sale of 506,331 shares.
Arrowhead Pharmaceuticals Inc (ARWR)'s detailed insider trading history can be found in Insider Trading Tracker table.
Arrowhead Pharmaceuticals Inc Insider Transactions
Backer Marianne De Mailing Address
Above is the net worth, insider trading, and ownership report for Backer Marianne De. You might contact Backer Marianne De via mailing address: 177 E Colorado Blvd, Suite 700, Pasadena Ca 91105.